← Open Payments lookup

ANGELA KOKINAKOS: Open Payments

NPI 1336786920 · EVERETT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,910 in 63 payments from 12 companies in 2025. Trend: 2023 $1,556 · 2024 $2,828 · 2025 $3,910

Food & beverage: $3,910
CompanyPaymentsAmount
ABBVIE INC.9$767
Axsome Therapeutics, Inc.10$712
Neurocrine BioSciences, Inc.10$672
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$575
E.R. Squibb & Sons, L.L.C.8$394
Otsuka America Pharmaceutical, Inc.8$270
Otsuka Pharmaceutical Development & Commercialization, Inc.1$147
Vanda Pharmaceuticals Inc.1$125
Alkermes, Inc.1$114
Teva Pharmaceuticals USA, Inc.1$89

Products named: VRAYLAR, Auvelity, INGREZZA, CAPLYTA, COBENFY, ABILIFY MAINTENA, REXULTI, FANAPT.

Industry payments across WA — which companies pay providers there.